| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
38 |
| Employees |
90 |
| Revenues (TTM) (Millions $) |
46 |
| Net Income (TTM) (Millions $) |
-1 |
| Cash Flow (TTM) (Millions $) |
-4 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Oncomed Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that is dedicated to developing oncology therapeutics that target cancer stem cells. The company was founded in 2004 and is headquartered in Redwood City, California.
Oncomed is focused on the discovery and development of first-in-class antibody therapeutics targeting the Wnt signaling pathway, which is critical for the growth and survival of cancer stem cells. The Wnt signaling pathway plays a key role in the development of various cancers, including breast, pancreatic, colorectal, and lung cancer.
Oncomed's lead product candidate is called vantictumab, also known as anti-FZD7, which is a monoclonal antibody that targets the Wnt signaling pathway. Vantictumab is currently being evaluated in clinical trials in combination with standard of care chemotherapy for the treatment of advanced solid tumors.
Oncomed also has other product candidates in its pipeline, including navicixizumab, anti-RSPO3, and anti-DLL4/VEGF bispecific antibody. Navicixizumab is being developed for the treatment of ovarian cancer and is currently in phase 1b/2 clinical trials. Anti-RSPO3 is being developed for the treatment of colorectal cancer and is in preclinical studies. Anti-DLL4/VEGF bispecific antibody is being developed for the treatment of solid tumors and is also in preclinical studies.
Oncomed has collaborations with several large pharmaceutical companies including Celgene, GlaxoSmithKline, and Bayer. The company has received funding from several venture capital firms, including US Venture Partners, Latterell Venture Partners, and The Vertical Group.The company has a highly experienced management team with expertise in drug development, clinical operations, and business development.
Overall, Oncomed Pharmaceuticals is a leading biopharmaceutical company dedicated to discovering and developing breakthrough cancer treatments through the targeting of cancer stem cells. Through its innovative approach and experienced management team, the company is well-positioned to play a significant role in the fight against cancer.
|
%